Search research articles
Contact Us
Filters
Showing results (61-70 of 244) with videos related to
Page
of 25
Sort By:
The Journal of Biological Chemistry
|
December 5, 2006
Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces
Relly Brandman, Marie-Hélène Disatnik, Eric Churchill, et al.
Journal of Biomedical Science
|
May 24, 2017
Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment
Jeewon Kim, Che-Hong Chen, Jieying Yang, et al.
Journal of Molecular and Cellular Cardiology
|
November 2, 2010
βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure
Julio Cesar Batista Ferreira, Patricia Chakur Brum, Daria Mochly-Rosen
Neuropharmacology
|
May 29, 2004
Cell-specific role for epsilon- and betaI-protein kinase C isozymes in protecting cortical neurons and astrocytes from ischemia-like injury
Jian Wang, Rachel Bright, Daria Mochly-Rosen, et al.
The Journal of Clinical Investigation
|
December 22, 2007
Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats
Xin Qi, Koichi Inagaki, Raymond A Sobel, et al.
Journal of Cell Science
|
December 15, 2012
A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity
Xin Qi, Nir Qvit, Yu-Chin Su, et al.
Brain Research
|
December 10, 2008
Activating deltaPKC antagonizes the protective effect of ERK1/2 inhibition against stroke in rats
Dora Castañeda, Heng Zhao, Daria Mochly-Rosen, et al.
Journal of the American Chemical Society
|
May 25, 2016
Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo
Nir Qvit, Marie-Hélène Disatnik, Eiketsu Sho, et al.
Molecular Genetics and Metabolism
|
September 22, 2016
Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells
Lauren D Van Wassenhove, Daria Mochly-Rosen, Kenneth I Weinberg
Annual Review of Pharmacology and Toxicology
|
October 9, 2007
PKC isozymes in chronic cardiac disease: possible therapeutic targets?
Eric Churchill, Grant Budas, Alice Vallentin, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 244) with videos related to
Sort By:
Page
of 25
The Journal of Biological Chemistry
|
December 5, 2006
Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces
Relly Brandman, Marie-Hélène Disatnik, Eric Churchill, et al.
Journal of Biomedical Science
|
May 24, 2017
Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment
Jeewon Kim, Che-Hong Chen, Jieying Yang, et al.
Journal of Molecular and Cellular Cardiology
|
November 2, 2010
βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure
Julio Cesar Batista Ferreira, Patricia Chakur Brum, Daria Mochly-Rosen
Neuropharmacology
|
May 29, 2004
Cell-specific role for epsilon- and betaI-protein kinase C isozymes in protecting cortical neurons and astrocytes from ischemia-like injury
Jian Wang, Rachel Bright, Daria Mochly-Rosen, et al.
The Journal of Clinical Investigation
|
December 22, 2007
Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats
Xin Qi, Koichi Inagaki, Raymond A Sobel, et al.
Journal of Cell Science
|
December 15, 2012
A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity
Xin Qi, Nir Qvit, Yu-Chin Su, et al.
Brain Research
|
December 10, 2008
Activating deltaPKC antagonizes the protective effect of ERK1/2 inhibition against stroke in rats
Dora Castañeda, Heng Zhao, Daria Mochly-Rosen, et al.
Journal of the American Chemical Society
|
May 25, 2016
Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo
Nir Qvit, Marie-Hélène Disatnik, Eiketsu Sho, et al.
Molecular Genetics and Metabolism
|
September 22, 2016
Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells
Lauren D Van Wassenhove, Daria Mochly-Rosen, Kenneth I Weinberg
Annual Review of Pharmacology and Toxicology
|
October 9, 2007
PKC isozymes in chronic cardiac disease: possible therapeutic targets?
Eric Churchill, Grant Budas, Alice Vallentin, et al.
Page
of 25